Posts by Justin Gainor, MD
-
Molecular Features Identified That Predict Response to Checkpoint Inhibitors in NSCLC
Justin Gainor, MD, and colleagues have published findings from the first joint analysis of the Stand Up To Cancer–Mark Foundation non-small cell lung cancer cohort, reporting newly identified genomic and transcriptomic biomarkers of response and resistance to anti–PD-1 and anti–PD-L1 immune checkpoint inhibitors.
-
About the Henri and Belinda Termeer Center for Targeted Therapies at the Mass General Cancer Center
Justin Gainor, MD, discusses the Henri and Belinda Termeer Center for Targeted Therapies at the Massachusetts General Hospital Cancer Center.
Biography
Justin Gainor, MD, is director of the Center for Thoracic Cancers Program and director of Targeted Immunotherapy at the Mass General Cancer Center, and an associate professor of Medicine at Harvard Medical School.
Mass General Cancer Center
An integral part of one of the world’s most distinguished academic medical centers, the Massachusetts General Hospital Cancer Center is among the leading cancer care providers in the United States.
